Navigation Links
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
Date:7/30/2009

---- ---- ---- ---- Operating expenses Research and development $4,648 $5,501 $11,524 $11,510 General and administrative 2,532 1,975 4,587 4,020 ----- ----- ----- ----- Total operating expenses(1) 7,180 7,476 16,111 15,530 Interest income and other, net 210 384 381 995 Gain from valuation of common stock warrant liability 440 - 440 - --- --- --- --- Total other income, net 650 384 821 995 Net loss(1) $(6,530) $(7,092) $(15,290) $(14,535) ======= ======= ======== ======== Net loss per share, basic and diluted(1) $(0.21) $(0.25) $(0.51) $(0.51) ====== ====== ====== ====== Shares used in calculating net loss per share, basic and diluted 31,493 28,731 30,173 28,714 ====== ====== ====== ====== (1) Includes non-cash operating expenses of $1,062 and $668 determined in accordance with Statement of Financial Accounts Standards No. 123(R), "Share-Based Payment" (SFAS No. 123(R)) or approximately $0.03 and $0.02 effect on basic and diluted net loss per common share for the three months ended June 30, 2009 and 2008, respectively. Research and development expense and general and administrative expense includes $616 and $446, respectively, of non-cash operating expenses determined in accordance with SFAS No. 123(R) for the three months ended June 30, 2009. Includes non-cash operating expenses of $1,746 and $1,329 determined in
'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
2. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
3. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
4. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
5. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
6. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
7. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
8. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
9. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
11. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... 2015 , ... This cutting edge standard making is a madatory tool for ... the WAV-8 is the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality ... Previous spectrophotometer calibration standards, such as those made from didymium glass were only able ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... around 19% during the forecast period (2015 to 2020). The market is mainly ... government and corporate funding for R&D. However, lack of adequate healthcare and research ...
(Date:6/29/2015)... , June 29, 2015  MiMedx Group, Inc. ... utilizing human amniotic tissue and patent-protected processes to develop ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... Parker H. "Pete" Petit, has been awarded the Lifetime ... 2015 Southeast Program. The Entrepreneur Of ...
(Date:6/29/2015)... ... ... The StampedeCon 2015 Big Data Conference will be taking place ... will bring top technology professionals to St. Louis. Top industry speakers will share their ... The event is proudly sponsored by DataStax, Cisco, World Wide Technology, Hortonworks, OCI, HP, ...
Breaking Biology Technology:FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2StampedeCon Announces 2015 Agenda 2StampedeCon Announces 2015 Agenda 3
... Last week, I was sent an announcement of pending ... on Jan. 25. Here's its synopsis: , Creates the ... of Central Management Services (CMS) to create and maintain ... forth that all publicly held broadband infrastructure shall be ...
... Wis. Cedara Software said it ... Axicare , a medical software company in Paris. Cedara ... a public medical information technology company headquartered in Milwaukee. ... data and workflow managment, which has been installed in ...
... topic of financing is vital to a biotech company (it ... use "biotech" in the broadest sense) companies are continually faced ... product development cycle, this week's article will focus on venture ... focused on VC financing results from Burrill and Company's data. ...
Cached Biology Technology:Proposed Illinois broadband act falls short 2Proposed Illinois broadband act falls short 3Proposed Illinois broadband act falls short 4Proposed Illinois broadband act falls short 5U.S. VC funding flat in 2005 while life science funding grows 2U.S. VC funding flat in 2005 while life science funding grows 3U.S. VC funding flat in 2005 while life science funding grows 4
(Date:6/24/2015)... June 24, 2015 The biologics safety testing ... drivers for the market include growth of the pharmaceutical ... drug launches. Over the years, the number of drug ... and 2010, the FDA approved 225 drug applications and ... Europe accounted for 3,822 of ...
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... LONDON, Dec. 17 Chiltern International Limited (Chiltern), a global ... in Europe, the Americas and Asia, is pleased to announce ... Epidemiology. , Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc ... served as Director of Epidemiology and Evidence-based Medicine at GlaxoSmithKline. ...
... a novel animal model showing that four commonly used ... and that the condition could be partially reversed with ... in the journal Cancer Investigation , the University ... legions of cancer survivors who experience a frustrating decline ...
... -- Companies and communities trying to restore vegetation on damaged ... growth according to new research published in the November issue ... all plants benefit from the use of fertilizers. In fact, ... at Universit Laval, and two colleagues spent a summer growing ...
Cached Biology News:Chiltern Announces Collaboration With Dr Nawab Qizilbash 2UR study reveals chemo's toxicity to brain, possible treatment 2UR study reveals chemo's toxicity to brain, possible treatment 3Fertilizer use not always helpful in revegetation efforts 2
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
Biology Products: